Share on StockTwits

Arrowhead Research Corp (NASDAQ:ARWR) posted its quarterly earnings results on Tuesday. The company reported ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.22), Analyst Ratings Network reports.

On the ratings front, analysts at Jefferies Group raised their price target on shares of Arrowhead Research Corp from $29.00 to $30.00 in a research note on Friday, June 20th. They now have a “buy” rating on the stock. Five investment analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average target price of $24.29.

Arrowhead Research Corp (NASDAQ:ARWR) traded up 1.17% on Tuesday, hitting $13.00. 6,179,821 shares of the company’s stock traded hands. Arrowhead Research Corp has a 52-week low of $3.75 and a 52-week high of $27.63. The stock’s 50-day moving average is $12.43 and its 200-day moving average is $15.02. The company’s market cap is $674.3 million.

Arrowhead Research Corporation (NASDAQ:ARWR) is a biopharmaceutical company developing targeted RNAi therapeutics.

Receive News & Ratings for Arrowhead Research Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Research Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.